Literature DB >> 17093191

Lysis of human immunodeficiency virus type 1 by a specific secreted human phospholipase A2.

Jae-Ouk Kim1, Bimal K Chakrabarti, Anuradha Guha-Niyogi, Mark K Louder, John R Mascola, Lakshmanan Ganesh, Gary J Nabel.   

Abstract

Phospholipase A2 (PLA2) proteins affect cellular activation, signal transduction, and possibly innate immunity. A specific secretory PLA2, sPLA2-X, is shown here to neutralize human immunodeficiency virus type 1 (HIV-1) through degradation of the viral membrane. Catalytic function was required for antiviral activity, and the target cells of infection were unaffected. sPLA2-X potently reduced gene transfer of HIV-1 Env-pseudotyped lentivirus vectors and inhibited the replication of both CCR5- and CXCR4-tropic HIV-1 in human CD4+ T cells. Virions resistant to damage by antibody and complement were sensitive to lysis by sPLA2-X, suggesting a novel mechanism of antiviral surveillance independent of the acquired immune system.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17093191      PMCID： PMC1797512          DOI： 10.1128/JVI.01790-06

Source DB:  PubMed          Journal:  J Virol        ISSN： 0022-538X            Impact factor:   5.103


  28 in total

1.  Efficient generation of recombinant adenoviral vectors by Cre-lox recombination in vitro.

Authors:  K Aoki; C Barker; X Danthinne; M J Imperiale; G J Nabel
Journal:  Mol Med       Date:  1999-04       Impact factor: 6.354

2.  Exogenously added human group X secreted phospholipase A(2) but not the group IB, IIA, and V enzymes efficiently release arachidonic acid from adherent mammalian cells.

Authors:  S Bezzine; R S Koduri; E Valentin; M Murakami; I Kudo; F Ghomashchi; M Sadilek; G Lambeau; M H Gelb
Journal:  J Biol Chem       Date:  2000-02-04       Impact factor: 5.157

Review 3.  Structure and function of phospholipase A2.

Authors:  H M Verheij; A J Slotboom; G H de Haas
Journal:  Rev Physiol Biochem Pharmacol       Date:  1981       Impact factor: 5.545

4.  Catalytic role of the active site histidine of porcine pancreatic phospholipase A2 probed by the variants H48Q, H48N and H48K.

Authors:  M J Janssen; W A van de Wiel; S H Beiboer; M D van Kampen; H M Verheij; A J Slotboom; M R Egmond
Journal:  Protein Eng       Date:  1999-06

5.  Structures of the catalytic site mutants D99A and H48Q and the calcium-loop mutant D49E of phospholipase A2.

Authors:  K Sekar; R Biswas; Y Li; M Tsai; M Sundaralingam
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  1999-02

6.  Susceptibility of HIV-1 plasma virus to complement-mediated lysis. Evidence for a role in clearance of virus in vivo.

Authors:  B L Sullivan; E J Knopoff; M Saifuddin; D M Takefman; M N Saarloos; B E Sha; G T Spear
Journal:  J Immunol       Date:  1996-08-15       Impact factor: 5.422

7.  Resistance of transgenic mice expressing human group II phospholipase A2 to Escherichia coli infection.

Authors:  V J Laine; D S Grass; T J Nevalainen
Journal:  Infect Immun       Date:  2000-01       Impact factor: 3.441

Review 8.  Complement-opsonized HIV: the free rider on its way to infection.

Authors:  Heribert Stoiber; Monika Pruenster; Christoph G Ammann; Manfred P Dierich
Journal:  Mol Immunol       Date:  2005-02       Impact factor: 4.407

9.  Arachidonic acid release from mammalian cells transfected with human groups IIA and X secreted phospholipase A(2) occurs predominantly during the secretory process and with the involvement of cytosolic phospholipase A(2)-alpha.

Authors:  Carine M Mounier; Farideh Ghomashchi; Margaret R Lindsay; Scott James; Alan G Singer; Robert G Parton; Michael H Gelb
Journal:  J Biol Chem       Date:  2004-03-08       Impact factor: 5.157

10.  The potent anti-Staphylococcus aureus activity of a sterile rabbit inflammatory fluid is due to a 14-kD phospholipase A2.

Authors:  Y Weinrauch; P Elsbach; L M Madsen; A Foreman; J Weiss
Journal:  J Clin Invest       Date:  1996-01-01       Impact factor: 14.808
View more
  15 in total

Review 1.  Phospholipase A2 enzymes: physical structure, biological function, disease implication, chemical inhibition, and therapeutic intervention.

Authors:  Edward A Dennis; Jian Cao; Yuan-Hao Hsu; Victoria Magrioti; George Kokotos
Journal:  Chem Rev       Date:  2011-09-12       Impact factor: 60.622

2.  In vitro anti-Plasmodium falciparum properties of the full set of human secreted phospholipases A2.

Authors:  Carole Guillaume; Christine Payré; Ikram Jemel; Louise Jeammet; Sofiane Bezzine; Gajendra S Naika; James Bollinger; Philippe Grellier; Michael H Gelb; Joseph Schrével; Gérard Lambeau; Christiane Deregnaucourt
Journal:  Infect Immun       Date:  2015-03-30       Impact factor: 3.441

3.  Antimalarial Activity of Human Group IIA Secreted Phospholipase A2 in Relation to Enzymatic Hydrolysis of Oxidized Lipoproteins.

Authors:  Mélanie Dacheux; Véronique Sinou; Christine Payré; Louise Jeammet; Daniel Parzy; Philippe Grellier; Christiane Deregnaucourt; Gérard Lambeau
Journal:  Infect Immun       Date:  2019-10-18       Impact factor: 3.441

4.  Secreted phospholipase A2 is increased in meconium-stained amniotic fluid of term gestations: potential implications for the genesis of meconium aspiration syndrome.

Authors:  Roberto Romero; Bo Hyun Yoon; Piya Chaemsaithong; Josef Cortez; Chan-Wook Park; Rogelio Gonzalez; Ernesto Behnke; Sonia S Hassan; Francesca Gotsch; Lami Yeo; Tinnakorn Chaiworapongsa
Journal:  J Matern Fetal Neonatal Med       Date:  2014-01-06

5.  Phospholipase A2 isolated from the venom of Crotalus durissus terrificus inactivates dengue virus and other enveloped viruses by disrupting the viral envelope.

Authors:  Vanessa Danielle Muller; Ricardo Oliveira Soares; Nilton Nascimento dos Santos; Amanda Cristina Trabuco; Adelia Cristina Cintra; Luiz Tadeu Figueiredo; Antonio Caliri; Suely Vilela Sampaio; Victor Hugo Aquino
Journal:  PLoS One       Date:  2014-11-10       Impact factor: 3.240

6.  Broad-spectrum antiviral agents: secreted phospholipase A2 targets viral envelope lipid bilayers derived from the endoplasmic reticulum membrane.

Authors:  Ming Chen; Chie Aoki-Utsubo; Masanori Kameoka; Lin Deng; Yutaka Terada; Wataru Kamitani; Kei Sato; Yoshio Koyanagi; Makoto Hijikata; Keiko Shindo; Takeshi Noda; Michinori Kohara; Hak Hotta
Journal:  Sci Rep       Date:  2017-11-21       Impact factor: 4.379

7.  Antiretroviral activity of Pterois volitans (red lionfish) venom in the early development of human immunodeficiency virus/acquired immunodeficiency syndrome antiretroviral alternative source.

Authors:  Andy Noorsaman Sommeng; R Muhammad Yusuf Arya; Mikael Januardi Ginting; Diah Kartika Pratami; Heri Hermansyah; Muhamad Sahlan; Anondho Wijanarko
Journal:  Vet World       Date:  2019-02-23

8.  Hypothesis of snake and insect venoms against Human Immunodeficiency Virus: a review.

Authors:  Ramachandran Meenakshisundaram; Shah Sweni; Ponniah Thirumalaikolundusubramanian
Journal:  AIDS Res Ther       Date:  2009-11-19       Impact factor: 2.250

9.  Lack of group X secreted phospholipase A₂ increases survival following pandemic H1N1 influenza infection.

Authors:  Alyson A Kelvin; Norbert Degousee; David Banner; Eva Stefanski; Alberto J Leόn; Denis Angoulvant; Stéphane G Paquette; Stephen S H Huang; Ali Danesh; Clinton S Robbins; Hossein Noyan; Mansoor Husain; Gerard Lambeau; Michael Gelb; David J Kelvin; Barry B Rubin
Journal:  Virology       Date:  2014-02-25       Impact factor: 3.616

10.  Antiviral activity of Acanthaster planci phospholipase A2 against human immunodeficiency virus.

Authors:  Anondho Wijanarko; Kenny Lischer; Heri Hermansyah; Diah Kartika Pratami; Muhamad Sahlan
Journal:  Vet World       Date:  2018-06-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.